药学学报
藥學學報
약학학보
ACTA PHARMACEUTICA SINICA
2008年
4期
402-407
,共6页
曲婷婷%张蕊%王本杰%刘晓燕%袁桂艳%郭瑞臣
麯婷婷%張蕊%王本傑%劉曉燕%袁桂豔%郭瑞臣
곡정정%장예%왕본걸%류효연%원계염%곽서신
倍他米松%LC-MS/MS%药代动力学%复方倍他米松注射液
倍他米鬆%LC-MS/MS%藥代動力學%複方倍他米鬆註射液
배타미송%LC-MS/MS%약대동역학%복방배타미송주사액
betamethasone%LC-MS/MS%pharmacokinetics%compound betamethasone injection
建立测定人血浆中倍他米松的LC-MS/MS方法.采用Venusil XBP C8(200 mm ×3.9 mm ID,5 μm)色谱柱,流动相为甲醇-水(含甲酸铵5 mmol·L-1)(80:20),流速0.4 mL·min-1;质谱仪离子源为电喷雾离子源(ESI),正离子模式检测,监测离子为393.3→355.2(倍他米松)和361.3→343.2(泼尼松龙,内标).血浆样本用乙酸乙酯处理.倍他米松在0.5~80.0 ng·mL-1线性关系良好(r=0.999 2),血浆低、中、高3种浓度(1.0,10.0,60.0ng·mL-1)平均提取回收率为88.24%,定量限为0.5 ng·mL-1.本方法操作简便、准确、灵敏,适用于复方倍他米松注射液人体药代动力学研究.
建立測定人血漿中倍他米鬆的LC-MS/MS方法.採用Venusil XBP C8(200 mm ×3.9 mm ID,5 μm)色譜柱,流動相為甲醇-水(含甲痠銨5 mmol·L-1)(80:20),流速0.4 mL·min-1;質譜儀離子源為電噴霧離子源(ESI),正離子模式檢測,鑑測離子為393.3→355.2(倍他米鬆)和361.3→343.2(潑尼鬆龍,內標).血漿樣本用乙痠乙酯處理.倍他米鬆在0.5~80.0 ng·mL-1線性關繫良好(r=0.999 2),血漿低、中、高3種濃度(1.0,10.0,60.0ng·mL-1)平均提取迴收率為88.24%,定量限為0.5 ng·mL-1.本方法操作簡便、準確、靈敏,適用于複方倍他米鬆註射液人體藥代動力學研究.
건립측정인혈장중배타미송적LC-MS/MS방법.채용Venusil XBP C8(200 mm ×3.9 mm ID,5 μm)색보주,류동상위갑순-수(함갑산안5 mmol·L-1)(80:20),류속0.4 mL·min-1;질보의리자원위전분무리자원(ESI),정리자모식검측,감측리자위393.3→355.2(배타미송)화361.3→343.2(발니송룡,내표).혈장양본용을산을지처리.배타미송재0.5~80.0 ng·mL-1선성관계량호(r=0.999 2),혈장저、중、고3충농도(1.0,10.0,60.0ng·mL-1)평균제취회수솔위88.24%,정량한위0.5 ng·mL-1.본방법조작간편、준학、령민,괄용우복방배타미송주사액인체약대동역학연구.
A sensitive and selective liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the determination of betamethasone in human plasma. The analyte was isocratically eluted on a Venusil XBP C8 column (200 mm ×3.9 mm ID, 5 μm) with methanol-water with a triple quad LC-MS/MS using ESI with positive ionization. Ions monitored in the multiple reaction monitoring (MRM) mode were m/z 393.3→355.2 for betamethasone and m/z 361.3→343.2 for prednisolone (IS). Betamethasone was extracted from 0.5 mL human plasma with ethyl acetate. The validation study demonstrated excellent precision and accuracy across the calibration range of 0.5 - 80.0 injection in healthy Chinese volunteers.